Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 50Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Surveys and Questionnaires 13Blood Specimen Collection 13Specimen Handling 10Magnetic Resonance Spectroscopy 5Surgical Procedures, Operative 4Radiotherapy 4Observation 4Data Collection 4ribociclib 3darolutamide 3Watchful Waiting 3Standard of Care 3Patient Reported Outcome Measures 3Mental Status and Dementia Tests 3Interviews as Topic 3Immune Checkpoint Inhibitors 3Hepatectomy 3Breath Tests 3Biopsy 3trastuzumab deruxtecan 2palbociclib 2atezolizumab 2X-Rays 2Ultrasonography 2Tomography, X-Ray Computed 2Sulfonylurea Compounds 2Restraint, Physical 2Neoadjuvant Therapy 2Methods 2Mass Screening 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Capecitabine × 30 days × Clear all
NCT07618078 2026-06-03

Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
900 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡